drugset / Trial / NCT07551167
A Clinical Study of HRS-5765 in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of HRS-5765 in healthy participants.
Timeline
- Start
- 2026-05-20
- Primary completion
- 2026-12
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5765 | Unknown | — | Oral |